Cellular efflux pump and interaction between cisplatin and paclitaxel in ovarian cancer cells

Oncology

Volumn 59, Issue 4, 2000, Pages 329-335

  Kamazawa, Shunji ^a   Kigawa, Junzo ^a   Minagawa, Yukihisa ^a   Itamochi, Hiroaki ^a   Shimada, Muneaki ^a   Takahashi, Masakuni ^a   Sato, Shinya ^a   Akeshima, Ryouji ^a   Terakawa, Naoki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

CDDP; Combination effect; MDR 1; MRP; Paclitaxel

Indexed keywords

CARRIER PROTEIN; CISPLATIN; GLUTATHIONE; MULTIDRUG RESISTANCE PROTEIN; PACLITAXEL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL LEVEL; CONTROLLED STUDY; DRUG EFFICACY; DRUG EXPOSURE; DRUG MECHANISM; DRUG POTENTIATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033668408     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012191     Document Type: Article

References (27)

1. Taxol binds to polymerized tubulin in vitro
2. Mechanism of action of taxol
3. Development of polyploidization in taxol-resistant human leukemia cells in vitro
4. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
5. 2 over 3 hours) with cisplatin or carboplatin in previously untreated ovarian cancer: An interim analysis
6. European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: High-dose versus low-dose and long versus short infusion
7. Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro
8. Induction of apoptosis by taxol and cisplatin and effect on cell cycle-related proteins in cisplatin-sensitive and -resistant human ovarian cells
9. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: Possible explanation for failure of combination therapy
10. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis
11. Gamma-glutamyl cysteine synthetase up-regulates glutathione and multidrug resistance-associated protein in patients with chemoresistant epithelial ovarian cancer
12. Multidrug resistance mediated by the multi-drug resistance protein (MRP) gene
13. Taxol: Mechanisms of action and resistance
14. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
15. Effects of (CPT-11) in combination with other anti-cancer agents in culture
16. High-performance liquid chromatographic assay for taxol in human plasma and urine and pharmacokinetics in a phase I trial
17. Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry
18. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
19. Coordinated induction of MRP/GS-X pump and γ-glutamylcysteine synthetase by heavy metals in human leukemia cells
20. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
21. A colorimetric micro-method for the determination of glutathione
22. In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: Preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin
23. Combined action of paclitaxel and cisplatin against wildtype and resistant human ovarian carcinoma cells
24. Taxol: Twenty years later, the story unfolds
25. In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubules
26. Functional characterization of the rat mdr1b encoded P-glycoprotein: Not all inducing agents are substrates
27. Effects of chronic ethacrynic acid exposure on glutathione conjugation and MRP expression in human colon tumor cells